May 1st 2025
Increased levels of human leukocyte antigen G (HLA-G) were associated with inferior overall survival.
Screening for Breast Cancer at Younger Ages Linked to Reduced Mortality
August 14th 2020Screening women aged 40 to 49 years for breast cancer reduced mortality by 25% in the first 10 years compared with waiting until at age 50 years and older, which is the common practice in the United Kingdom.
Read More
Differences in the Risk of Orthopedic Surgery for Patients With RA, Psoriatic Arthritis
August 14th 2020The risk of orthopedic surgery has declined for patients with rheumatoid arthritis (RA) over the course of decades, but the same trend has not occurred for patients with psoriatic arthritis.
Read More
Fatigue Is Prevalent and Corresponds to Disease Severity in Asian Patients With Psoriatic Arthritis
August 12th 2020Most studies have evaluated PsA-associated fatigue in western populations. A new study has highlighted that PsA-associated fatigue is also prevalent in an Asian population and correlates with disease activity, impact, and chronicity.
Read More
Study Finds Bacterial Infections Linked to Coronary Heart Disease in Patients With T1D
August 12th 2020In individuals with type 1 diabetes (T1D), bacterial infections are associated with an increased risk of coronary heart disease, according to a study published in the Journal of Internal Medicine.
Read More
Asymptomatic Patients May Leave COVID-19 Viral Material on Surfaces Following Eye Exams
August 11th 2020Despite triage systems in place to exclude patients with coronavirus disease 2019 (COVID-19), viral material was found on ophthalmology examination room surfaces at one center, though the infectivity of the samples was unknown.
Read More
Reorganization of Sickle Cell Care Leads to Dramatic Drop in Hospitalizations
August 7th 2020Yale New Haven Hospital’s reorganization of its sickle cell disease program led patients to report feeling better off and needing fewer hospitalizations. However, the change left some with the disease still feeling unsatisfied.
Read More
Cancer Care in the Age of COVID-19: Dr Patricia Salber Interviews Dr Bobby Reddy
August 5th 2020Patricia Salber, MD, MBA, of The Doctor Weighs In, and Sandeep “Bobby” Reddy, MD, an oncologist at Harbor-UCLA Medical Center and chief medical officer of NantHealth, discuss the clinical care of patients with cancer in the age of COVID-19.
Listen
Experts Highlight COVID-19 Vaccine Developments and Remaining Challenges
August 4th 2020The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.
Read More
Comorbidity Burden for HFpEF, HFrEF on the Rise Among Women and Men
August 4th 2020Evidence may support a greater comorbidity burden among patients with heart failure with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF), although this finding was shown to be worse among women with HFpEF.
Read More
ACR Issues Advice on Reopening Clinics During the COVID-19 Pandemic
July 30th 2020During the coronavirus disease 2019 (COVID-19) pandemic, clinics have closed to varying degrees. As clinics look to reopen or welcome back patients after a COVID-19 infection, the American College of Rheumatology (ACR) has released advice on strategies for reopening practices as the pandemic continues.
Read More
The Race to Find a COVID-19 Vaccine
July 28th 2020The race for a coronavirus disease 2019 (COVID-19) vaccine is one of the most urgent public health challenges, with multiple vaccine candidates entering phase 3 trials and case counts around the world steadily climbing. MJH Life Sciences™ will host a free webinar with the top minds in infectious disease, virology, and vaccinology to discuss the latest trial information on vaccines.
Read More
Tocilizumab Caused Serious AEs in a Quarter of Children With Rheumatic Inflammatory Diseases
July 25th 2020In children with inflammatory rheumatic diseases, tocilizumab can cause serious adverse events (AEs), with children who were younger at disease onset and at time of tocilizumab initiation especially affected.
Read More
One in 5 Patients With MS Don't Adhere to Oral DMDs
July 24th 2020The researchers noted that these results can help inform therapeutic decision making and identify opportunities to address barriers to disease-modifying drug (DMD) adherence, which not only improves clinical outcomes but also reaps benefits when it comes to health care costs.
Read More